$34.50

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI02056_25_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate
Brand Name
Chem Impex
Product Number
02056
CAS
125700-67-6
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
2733207
IUPAC Name
benzotriazol-1-yloxy(dimethylamino)methylidene-dimethylazanium tetrafluoroborate
InChI Key
JKEKMBGUVUKMQB-UHFFFAOYSA-N
SMILES
B-(F)(F)(F)F.CN(C)C(=N+(C)C)ON1C2=CC=CC=C2N=N1

Application

O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate is widely utilized in research focused on:

Organic Synthesis: This compound serves as an effective reagent in various organic reactions, facilitating the formation of complex molecules with high efficiency.

Photochemical Applications: It is used in photochemical studies due to its ability to absorb UV light, making it valuable in the development of light-sensitive materials and coatings.

Polymer Chemistry: The compound plays a crucial role in polymerization processes, enhancing the properties of polymers used in coatings, adhesives, and sealants.

Analytical Chemistry: It is employed as a reagent in analytical techniques, aiding in the detection and quantification of various substances in complex mixtures.

Biochemical Research: This chemical is beneficial in biochemical assays, particularly in studying enzyme activities and interactions, providing insights into biological processes.

References

Comparison of Alternative Piperidine Deblocking Agents in the Solid-Phase Synthesis of Ingramon and Methylin

Publication Name: Russian Journal of Bioorganic Chemistry
Publication Date: 2025-07-28
DOI: 10.1134/s1068162025602733

Integrated experimental and in silico studies on thiophene carboxamide derivatives: synthesis, characterization, and biological evaluation

Publication Name: Journal of the Iranian Chemical Society
Publication Date: 2025-07-15
DOI: 10.1007/s13738-025-03248-2

First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases

Publication Name: Pharmaceutical Research
Publication Date: 2025-06-25
DOI: 10.1007/s11095-025-03882-8